跳至主要内容
临床试验/IRCT20190701044062N1
IRCT20190701044062N1招募中早期 1 期

Evaluation of Sodium Pentaborate Topical Ointment on Hemorrhoid Symptoms

Tabriz University of Medical Sciences0 个研究点目标入组 53 人开始时间: 待定最近更新:

试验速览

阶段
早期 1 期
状态
招募中
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 65-18 years old
  • Patients with hemorrhoids and those with I, II, III or IV internal hemorrhoid disorder without need for emergency interventions based on physical examination
  • The presence of anal bleeding as one of the symptoms of a hemorrhoid in the patient (according to the Sodergren scoring system)
  • Non-use of a drug other than the drug and control drug for the treatment of hemorrhoids during the study period

排除标准

  • Disorders and analgesics including inflammatory bowel disease, Fisher, fistula and perianal rash, rectal prolapse, rectus, benign or malignant tumor of the anus and rectum, and perianal infections
  • Patients with sodium phentetrazur susceptibility or a history of skin sensitivity to vaseline
  • Pregnancy or breastfeeding
  • Patients with severe heart disease, neurology, liver and kidney disease and blood diseases
  • Taking any local analgesic for the past 7 days
  • Prohibition of topical use of vaseline or sodium panteurate
  • The history of permanent prolapse is the entire thickness of the rectum

研究者

相似试验